Evidence map›Paper›PMID 42542778›Full record

ArticleOpen forum infectious diseases2026

Interobserver Agreement for Classifying Infections in Emergency Department Patients Using Modified Centers for Disease Control and Prevention Criteria.

Oren Turgman, Evelien Reijnders, Sebastiaan C M Joosten, Susanne E Doeleman, Aryna Kolodyazhna, Floris M C de Vries, Renée A Douma, Hazra S Moeniralam, Hessel Peters-Sengers, Stephanie Popping and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Oren TurgmanCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7918-9915
Evelien ReijndersCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Sebastiaan C M JoostenCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Susanne E DoelemanCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Aryna KolodyazhnaCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Floris M C de VriesCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.
Renée A DoumaDepartment of Internal Medicine, Flevo Hospital, Almere, The Netherlands.
Hazra S MoeniralamDepartment of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
Hessel Peters-SengersCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3145-864X
Stephanie PoppingCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8959-4671
Tom van der PollCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-9199-5079
W Joost WiersingaCentre for Infection and Molecular Medicine, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To develop and evaluate a standardized emergency department (ED) adapted framework based on Centers for Disease Control (CDC) surveillance definitions and modified SOFA assessment for reproducible infection and sepsis classification in patients with suspected infection on the ED. Methods: As part of the prospective cohort study BIOSEP, adults presenting to the ED with suspected infection and a Modified Early Warning Score ≥2 were consecutively enrolled between 2022 and 2026 at 4 Dutch hospitals. All enrolled patients in this study were retrospectively adjudicated through post hoc review of their electronic health records. Each case was independently assessed by 2 blinded physicians for plausibility of infection, infection diagnosis, causative pathogen, and sepsis occurrence. Disagreements were resolved by a third blinded reviewer. Interobserver agreement was quantified using Cohen's kappa and Gwet's agreement coefficients (gAC). Results: In total, 1062 ED patients were included with 1145 infection episodes. Interobserver agreement for infection diagnosis was 88.9%, and agreement statistics were classified as very good with Cohen's κ of 0.87 (95% CI 0.85-0.89) and a gAC1 of 0.89 (0.87-0.91). Agreement for causative pathogens was 90.1% (κ 0.89 [0.87-0.92]; gAC1 0.97 [0.95-0.98]), and for sepsis occurrence 93.4% (κ 0.80 [0.76-0.85]; gAC1 0.92 [0.90-0.94]). Agreement for plausibility of infection was also high (87.9%; weighted κ 0.87 [0.85-0.89]; gAC2 0.92 [0.90-0.93]). Conclusions: Our ED-adapted adjudication framework based on CDC surveillance definitions yields high interobserver agreement for infection and sepsis classification across a heterogeneous ED population, supporting its use in large-scale observational research.

Indexed as

classificationdiagnosisemergency departmentinfectious diseasesinterobserver variability

Identifiers

PMID42542778
PMCPMC13428169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.